Kinases
Targeting a kinase? Find out how BMG LABTECH microplate readers measure interaction with kinases, kinase activities and kinase inhibitors in high throughput.
Measuring thousands of wells in minutes, as needed for compound screens, requires extremely fast and sensitive instrumentation – the perfect task for BMG LABTECH plate readers.
An essential part of the early phase of drug discovery is screening libraries of compounds in order to detect potential ‘hits’ which interact with a therapeutic target. Common targets include membrane proteins such as GPCRs as well as kinases and PROTACS. Compounds acting on a therapeutic target have to be identified out of libraries of thousands to millions of compounds, making automation of the process using microplate readers essential.
Screens are mainly conducted in 384 and 1536 well plates to minimize reaction volumes per sample. Speed and sensitivity are key requirements for screeners. A 1536 well microplate needs to be measured in seconds, maximally a few minutes. Furthermore, the fast measurement of 10 µl or even lower volume samples needs to be very precise and stable to clearly identify hits from a vast number of compounds. In addition, the reader needs to be reliable, as errors occurring during a screen result in repetitions, loss of time, reagents and consequently money.
BMG LATBECH’s multi-mode microplate readers have market leading performance ensuring hits can be reliably detected at low volumes and at the fastest speeds. This not only enables the highest throughput but also allows rapid cycle times in kinetic assays required for studying binding kinetics and on/off rates.
The PHERAstar FSX masters all these requirements in all detection modes, making it popular in screening facilities. For screening assay development and testing, the CLARIOstar Plus is the perfect addition to develop and characterize an assay before transitioning to high throughput.
Take a look at the links below to find out more about our instruments and how they have been used by drug screeners.
Receptors
GPCRs are the top drug targets. Numerous assays study ligand binding, receptor signaling, or binding kinetics in high throughput. Measure them on a single reader.
Resources
Search our resources section for information about specific applications, literature citations, videos, blog articles and many other publications. Many of the resources provided are associated with current and previous instrument models and versions.
Viral Cytopathic effects measured in a drug discovery screen
Are you looking for a label-free method to study potential antiviral drugs? This AppNote presents a fast and cheap way to study viral cytopathic effects with cell viability/toxicity assays.
Identification of false positives in a HTRF® screen for small molecule inhibitors of PD-1/PD-L1
Are you tired of false positive hits affecting your results? In this application note you will find two options for identifying false positive compounds via HTRF measurement.
Antiviral assay based on expression of fluorescent proteins by the viruses
Are you looking for an easy way to screen for antivirals in 384-well format? This application is ideally suited to investigate virus uptake and replication in living cells.
High-throughput ELISA ready to analyse in 90-minutes: 384-well SimpleStep ELISA® with the PHERAstar® FSX
Did you know, that the 90 min SimpleStep ELISA®s by abcam also work in 384-well format? Read here why our dedicated high-throughput reader PHERAstar® FSX is the perfect match for HTS.
Studying the molecular mechanism of viral replication in real time using the CLARIOstar Plus with ACU
Looking for methods to study the molecular mechanisms of viral replication? In this AppNote a fluorescence-based approach for real-time measurement of viral gene expression is presented.
Binding kinetics: high throughput assay for kinase inhibitors
Studying binding kinetics helps to reduce clinical failure of potential drugs. Read here, how TR-FRET can be used to determine association and dissociation rates of unlabelled compounds.
Binding kinetics
The investigation of binding kinetics is crucial for drug research. Find out, how binding kinetics work and which approaches can be used to study them on microplate readers.
NanoBRET
NanoBRET is used to analyse binding events, signaling pathways and receptor trafficking in live cells and has significantly expanded the range and applications of BRET assays.
Binding Assays - More Than One Way to Achieve your Goals
Overwhelmed with the abundance of assay options? This blog compares the various advantages and disadvantages of different approaches available for binding assays.
How to determine binding affinity with a microplate reader?
The determination and optimisation of binding affinity are of great importance for the development of new drugs and treatment options. Read more here.
Transcreener® assays
Read here how you can perform Transcreener® assays to e.g. quantify AMP on the powerful and sensitive microplate readers from BMG LABTECH.
Monoclonal antibody drugs – a history of success and a bright future!
The use of monoclonal antibody drugs for therapeutic outcomes remains a topic of high interest throughout the research community. Read more on their history and promises here.
Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum, using a nano luciferase reporter read-out
Dechering, KJ;Timmerman, M;Rensen, K;Koolen, KMJ;Honarnejad, S;Vos, MW;Huijs, T;Henderson, RWM;Chenu, E;Laleu, B;Montefiore, BC;Segall, MD;Mills, JEJ;Guantai, EM;Duffy, J;Duffey, M; [2022]
SLAS discovery : advancing life sciences R & D
Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity
Dengler, DG;Sun, Q;Harikumar, KG;Miller, LJ;Sergienko, EA; [2022]
SLAS discovery : advancing life sciences R & D
Screening the Tocriscreen™ bioactive compound library in search for inhibitors of Candida biofilm formation
Abduljalil, H;Bakri, A;Albashaireh, K;Alshanta, OA;Brown, JL;Sherry, L;Kean, R;Nile, C;McLean, W;Ramage, G; [2022]
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay
Frische, A;Brooks, PT;Gybel-Brask, M;Sækmose, SG;Jensen, BA;Mikkelsen, S;Bruun, MT;Boding, L;Strandh, CP;Jørgensen, CS;Krogfelt, KA;Fomsgaard, A;Lassauniere, R; [2022]
PloS one 17(7) e0272298
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors
van Klaveren, S;Dernovšek, J;Jakopin, Ž;Anderluh, M;Leffler, H;Nilsson, UJ;Tomašič, T; [2022]
RSC advances 12(29) 18973-18984
Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway
Imran, A;Shehzad, MT;Shah, SJA;Laws, M;Al-Adhami, T;Rahman, KM;Khan, IA;Shafiq, Z;Iqbal, J; [2022]
ACS omega 7(30) 26425-26436
Binding affinity determination on microplate readers
Binding affinity is an important parameter in drug discovery. Find out, how microplate readers can be used for binding affinity determination and the advantages they offer.
Using the TRUPATH BRET platform to analyse GPCR biased agonism
TRUPATH is a BRET-based platform that enables to monitor discrete GPCR-G protein coupling and can facilitate the discovery of drugs biased towards desired G protein effectors.
Current microplate-based interaction assays for drug discovery
Protein-protein interaction is the key in physiological processes - and likewise many diseases. Learn here about possible approaches to study interactions in drug screening using NanoBRET and TR-FRET.
Kinetics in Drug Discovery
Martin Redhead, group leader at UCB, discusses the use and impact of kinetic binding methods across the drug discovery pipeline.
Miniaturising screening assays: a case study
Watch here, how the PHERAstar’s extraordinary sensitivity allows to detect TR-FRET assays with high reliability and reproducibility even in miniaturized sample volumes using 1536-well plates.
Cell-based and biochemical high-throughput screening in 1536-well plates
Learn more on successful miniaturization approaches and high-throughput screening attempts in 1536-well plates employing the CRISPR/Cas9 system to knock in Nano luciferase reporter genes.
From assay development to compound screening
Joao used a CLARIOstar Plus and a PHERAstar FSX, for assay development and compound screening against a viral exonuclease.
Simplifying laboratory automation
David Reed (Managing Director at Flexible Lab Solutions) talks about the seamless integration of the BMG LABTECH microplate reader PHERAstar FSX into this system.
High-throughput screening of cyclic peptide libraries for developing drugs to challenging targets
Prof. Heinis´ work focusses on the use of cyclic peptides as drugs. Here he discusses the benefits of this approach and in how the PHERAstar FSX supports his screening needs.
Searching for optimised drugs: combining AI with human expertise
Read in this interview how Martin Redhead from Exscientia searches for optimised drugs and combines AI with human expertise.
Streamlined and more efficient drug screening with the PHERAstar FSX
Zaida Gloria talks about why she chose the PHERAstar FSX and how this plate reader makes her job easier.
Improving hit discovery efficiency at Europe’s leading screening centre
Read in this interview with Steven van Helden,Chief Technology Officer at Pivot Park Screening Centre (PPSC), how you can improve your hit discovery efficiency.
PHERAstar FSX
Powerful and most sensitive HTS plate reader
CLARIOstar Plus
Most flexible Plate Reader for Assay Development
NEPHELOstar Plus
Microplate nephelometer for light-scattering and turbidity measurements